PT Mitra Keluarga Karyasehat (MIKA) Q2 2026 earnings summary

Executive summary

• Delivered strong revenue and earnings growth in 1H26, driven by higher revenue intensity, improved payer mix, and expansion of high-complexity and specialty services.

• Maintained a robust balance sheet with zero or minimal debt, significant net cash, and strong equity position.

• Net revenue for 1H26 reached Rp2.77 trillion, with net profit attributable to owners at Rp684.1 billion.

• Total assets as of June 30, 2026 stood at Rp9.98 trillion, with equity attributable to owners at Rp7.31 trillion.

Financial highlights

• Revenue reached Rp2.77T, up 8.0% year-over-year; EBITDA grew 7.4% to Rp1.06T; net income rose 6.5% to Rp728B.

• Gross margin remained strong at 53.4%–53.5% (vs 54.7% in 1H25).

• Private revenue mix increased to 90% (from 88% in 1H25); covered patients rose to 62% (from 58%).

• Basic and diluted EPS was Rp49.25, up from Rp46.00 year-over-year.

• Cash and cash equivalents increased to Rp2.85T–Rp3.02T; net cash position with zero or minimal debt.

Outlook and guidance

• Ongoing capacity expansion with two new hospitals under development, targeting up to 1,400 additional beds.

• Continued investment in advanced medical technology and specialty centers to drive clinical excellence.

• Focus on increasing high-complexity care and further improving payer mix for sustainable growth.

• Expansion of healthcare services through subsidiaries and ongoing hospital construction projects.

• Prudent approach to liquidity and capital structure to support future growth and maximize shareholder value.